Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
14.87
+0.91 (6.52%)
At close: Aug 10, 2026, 4:00 PM EDT
14.79
-0.08 (-0.54%)
Pre-market: Aug 11, 2026, 4:55 AM EDT
Summit Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 419.37 | 225.27 | 104.86 | 71.43 | 348.61 | 71.79 |
Short-Term Investments | 271.31 | 488.18 | 307.49 | 114.82 | - | - |
Cash & Short-Term Investments | 690.68 | 713.45 | 412.35 | 186.24 | 348.61 | 71.79 |
Cash Growth | 131.87% | 73.02% | 121.41% | -46.58% | 385.59% | 8.09% |
Accounts Receivable | - | - | - | - | 0.35 | 1.46 |
Other Receivables | - | - | 0.56 | 0.85 | 5.77 | 15.7 |
Total Trade Receivables | - | - | 0.56 | 0.85 | 6.12 | 17.16 |
Other Current Assets | 29.9 | 6.85 | 10.84 | 2.62 | 301.99 | 8.36 |
Total Current Assets | 720.58 | 720.3 | 423.75 | 189.71 | 656.71 | 97.31 |
Net Property, Plant & Equipment | 19.41 | 20.62 | 7.4 | 6.06 | 5.08 | 3.48 |
Other Intangible Assets | - | - | - | - | - | 10.4 |
Goodwill | 1.97 | 2 | 1.86 | 1.89 | 1.8 | 2.01 |
Other Long-Term Assets | 8.45 | 7.21 | 2.55 | 5.28 | 0.58 | 0.17 |
Total Assets | 752.19 | 751.18 | 435.56 | 202.95 | 664.17 | 113.37 |
Accounts Payable | 22.9 | 20.29 | 4.64 | 2.67 | 0.36 | 4.37 |
Accrued Expenses | 74.5 | 47.03 | 31.53 | 14.21 | 16.31 | 11.32 |
Short-Term Debt | - | - | - | - | 19.77 | - |
Current Portion of Leases | 3.55 | 3.39 | 3.77 | 2.81 | 1.69 | 1.09 |
Unearned Revenue | - | - | - | - | - | 7.94 |
Other Current Liabilities | 2.62 | 2.28 | 1.8 | 0.72 | 0.66 | 0.9 |
Total Current Liabilities | 103.57 | 72.99 | 41.73 | 20.41 | 38.78 | 25.62 |
Long-Term Debt | - | - | - | 100 | 494.54 | - |
Long-Term Leases | 16.83 | 17.5 | 3.45 | 3.29 | 2.76 | 1.69 |
Other Long-Term Liabilities | 1.8 | 1.83 | 1.63 | 1.56 | 1.43 | 2.78 |
Total Long-Term Liabilities | 18.64 | 19.33 | 5.08 | 104.85 | 498.73 | 4.47 |
Total Liabilities | 122.2 | 92.32 | 46.81 | 125.26 | 537.51 | 30.09 |
Common Stock | 7.93 | 7.75 | 7.38 | 7.02 | 2.11 | 0.98 |
Additional Paid-in Capital | 3,324 | 2,948 | 1,598 | 1,066 | 504.77 | 384.05 |
Accumulated Other Comprehensive Income | -2.67 | -2.54 | -2.29 | -2.45 | -1.89 | -2.2 |
Retained Earnings | -2,699 | -2,294 | -1,215 | -993.26 | -378.33 | -299.55 |
Shareholders' Equity | 629.98 | 658.86 | 388.75 | 77.69 | 126.65 | 83.28 |
Total Liabilities & Equity | 752.19 | 751.18 | 435.56 | 202.95 | 664.17 | 113.37 |
Total Debt | 20.38 | 20.89 | 7.22 | 106.1 | 518.76 | 2.78 |
Net Cash (Debt) | 670.29 | 692.56 | 405.13 | 80.14 | -170.16 | 69.01 |
Net Cash Growth | 129.30% | 70.95% | 405.51% | - | - | 4.63% |
Net Cash Per Share | 0.88 | 0.93 | 0.56 | 0.13 | -0.88 | 0.52 |
Book Value | 629.98 | 658.86 | 388.75 | 77.69 | 126.65 | 83.28 |
Book Value Per Share | 0.82 | 0.88 | 0.54 | 0.13 | 0.66 | 0.63 |
Tangible Book Value | 628.02 | 656.86 | 386.88 | 75.8 | 124.86 | 70.88 |
Tangible Book Value Per Share | 0.82 | 0.88 | 0.54 | 0.12 | 0.65 | 0.54 |